Francois Rochon - Giverny Capital
Holding/activity history for Novo Nordisk A S (NVO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 12,400 | 0.06 | $119.03 | ||
| 2024 Q2 | 12,400 | 0.07 | $142.74 | ||
| 2024 Q1 | 12,400 | 0.06 | $128.39 | ||
| 2023 Q4 | 12,400 | 0.06 | $103.47 | ||
| 2023 Q3 | 12,400 | 0.06 | $90.97 | ||
| 2023 Q2 | 12,400 | 0.05 | $80.89 | ||
| 2023 Q1 | 12,400 | 0.06 | $79.60 | ||
| 2022 Q4 | 12,400 | 0.05 | $67.66 | ||
| 2022 Q3 | 12,400 | 0.04 | $49.84 | ||
| 2022 Q2 | 12,400 | 0.05 | $55.73 | ||
| 2022 Q1 | 12,400 | 0.04 | $55.56 | ||
| 2021 Q4 | 12,400 | 0.04 | $55.97 | ||
| 2021 Q3 | 12,400 | 0.04 | $47.98 | ||
| 2021 Q2 | 12,400 | 0.03 | $41.85 | ||
| 2021 Q1 | 12,400 | 0.03 | $33.71 | ||
| 2020 Q4 | 12,400 | 0.03 | $34.92 | ||
| 2020 Q3 | 12,400 | 0.04 | Buy | 0.04 | $34.68 |